SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Good morning ladies and gentlemen, and welcome to The Natural Gas Services Group Third Quarter 2021 Earnings Call. At this time, all participants are in listen-only mode. [Operator Instructions] Your ...
This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text component.
Our OncomineWorld events in 2020 and 2021 brought thousands of professionals together from around the world to advance understanding of next-generation sequencing in precision oncology research. The ...
Thermo Fisher Scientific Inc. TMO and AstraZeneca AZN have collaborated under a multiyear global agreement to co-develop next-generation sequencing (“NGS”)-based companion diagnostics (CDx). Through ...
Molecular biomarkers informing disease diagnosis, prognosis, and treatment decisions in patients with breast cancer are being uncovered by next-generation sequencing (NGS) technologies. In this study, ...
South San Francsico-based Twist Bioscience Corp. and Biotia Inc., of New York, received the first FDA emergency use authorization (EUA) for a capture-based next-generation sequencing (NGS) assay for ...
No audio available for this content. This column details the potential effects of crustal movement on published heights in various regions of the United States. In my last column (in the April 2021 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results